h124967
Loading viewer...
report
Format: PDF report
This Public Assessment Report details the scientific discussion and approval process for Sorafenib Alvogen 200 mg, a treatment for hepatocellular and renal cell carcinoma.
Loading viewer...
report
Format: PDF report
This Public Assessment Report details the scientific discussion and approval process for Sorafenib Alvogen 200 mg, a treatment for hepatocellular and renal cell carcinoma.
report
REC Silicon
report
Cat Technologies
report
Corbis
report
Norton Healthcare
